Depression, anxiety, and somatization influence the recovery of people with musculoskeletal pain. A Delphi study was conducted to reach consensus on the most appropriate self-administered questionnaires to assess these psychosocial factors in people at risk of developing persistent musculoskeletal pain. A multidisciplinary panel of international experts was identified via PubReMiner. The experts (N = 22) suggested 24 questionnaires in Round 1. In Round 2, experts rated the questionnaires on suitability, considering clinimetrics, content, feasibility, personal experiences, and expertise. The highest ranked questionnaires were retained for Round 3, in which the experts made a final assessment of the suitability of the questionnaires. Sensitivity analyses were performed to assess the impact of 1) not all experts having participated in each round, and 2) experts having been involved in relevant questionnaire development. Consensus (ie, ≥75% agreement) was reached for the following questionnaires.
Introduction
Low back pain and neck pain are the leading causes of disability. 14, 15 Major depressive and anxiety disorders are the third and ninth leading causes of disability. 14 Moreover, spinal pain, depression, and anxiety often coexist: 15 to 45% of people with persistent pain also experience some form of depression and/or anxiety. 3, 24, 25 When these comorbidities exist, healthcare costs are considerable higher. 27, 28 Besides psychosocial factors regarding dealing with pain (such as fear of movement, pain catastrophizing, low pain self-efficacy, and passive pain coping), depression, anxiety and somatization, influence the prognosis of people with musculoskeletal pain. 3, 18, 36 Positively influencing these psychosocial factors optimizes recovery. 2, 31, 32 However, recent studies reveal that primary care practitioners (other than mental health practitioners), such as general practitioners 18 and allied health clinicians 1, 6, 13 do not feel competent or equipped to assess psychosocial factors, particularly in people with persistent pain.
Self-report questionnaires can support decision-making in people with musculoskeletal pain. 6 Furthermore, clinical guidelines for musculoskeletal conditions typically recommend to assess psychosocial prognostic factors. 4, 5, 21, 22 However, these guidelines provide little or no direction as to which questionnaires should be used to assess psychosocial factors in people presenting with musculoskeletal pain, such as low back pain or neck pain. This is problematic as a plethora of questionnaires to assess psychosocial factors complicates comparison and pooling of data. In order to recommend questionnaires, it seems advisable to seek expert opinion from professionals in research who are experienced in this particular patient group. To reach a consensus in an international group of experts, a Delphi study can be used to provide recommendations. 20, 33 The aim of this study was therefore to reach consensus on the most relevant and feasible self-administered questionnaires that can be used in primary care to evaluate depression, anxiety, and somatization in people with musculoskeletal pain (such as low back pain or neck pain) at risk for the development or maintenance of persistent pain through a Delphi study.
Methods
We conducted a modified Delphi study 12 to identify and reach consensus on the most appropriate selfadministered questionnaires to assess depression, anxiety, and somatization in patients at risk for the development or maintenance of persistent musculoskeletal pain (eg, back pain and neck pain). This study can be considered as a modified Delphi study as the number of rounds was predetermined at 3 33 ; we did not provide individual feedback to the experts during the rounds; all experts were asked to complete the next round regardless of their participation in the previous round. 12 The criteria to be considered an expert, the definition of consensus as well as the analysis method were also decided prior to the study.
A separate Delphi study was conducted which focused on the assessment of fear of movement, pain catastrophizing, pain self-efficacy, and pain coping. 34 The 2 Delphi studies ran concurrently, but independently from each other. Twelve experts participated in both Delphi studies.
The study was approved by the local human ethics committee (VCWE-2016-223; Scientific and Ethical Review Board, Faculty of Behavioural and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands), and all participants provided digital informed consent.
Expert Panel
We used PubReMiner (PubMed, US National Library of Medicine, Bethesda, MD) to identify potential experts. PubReMiner is part of Pubmed and is a front-end for the PubMed literature database at the NCBI. It is comparable to a search in the PubMed database but allows easy identification of authors who are most active in the field of the specific query. Therefore, PubReMiner is particularly helpful in finding experts in a specific area. The search strings are listed in Appendix A. Experts were eligible to participate if 1) they (co)authored at least 6 relevant articles published in peer-reviewed journals, assessing at least 1 of the 3 psychosocial risk factors using self-administered questionnaires in people with musculoskeletal or persistent pain and 2) were able to complete the surveys for the 3 Delphi rounds in the suggested time-frame (February to August 2017). The expert criteria were determined in a focus meeting of clinical researchers (N = 5) with a psychology or allied health background. The identity of the experts remained unknown to the other experts during the 3 Delphi rounds. The identity of the experts was only known to the researchers, but the analysis was performed in a blinded fashion.
There is little empirical evidence on the optimal number of experts to achieve a reliable and valid consensus process. 30 However, most Delphi studies use panels that consist of approximately 15 to 20 experts. 19, 30 Procedure The number of rounds was pre-determined at 3, and anonymous electronic surveys were used (Qualtrics, Software version 2017, Provo, UT). Eligible experts received an invitation via email with a link to access the digital survey. For each round, nonresponders received an electronic reminder after 1 and 2 weeks, the rounds were open for 3 weeks in total. The experts had the option to omit 1 or more of the 3 domains (depression, anxiety, and somatization) if they did not consider themselves an expert for that domain. The experts were subsequently asked to provide the reason(s) why they decided to omit that particular psychosocial factor. No individualized feedback was given between rounds.
Round 1
In Round 1, the experts were asked to list the selfadministered questionnaires they believed were relevant to assess depression, anxiety or somatization in people at risk of developing or maintaining persisting musculoskeletal pain (such as low back pain and neck pain). Two investigators (L.B. and M.S.K.) retrieved all suggested questionnaires, and identified and summarized the clinimetric properties of each questionnaire (ie, internal consistency, test-retest reliability, and construct validity in a relevant target population, and feasibility [eg, the number of items and time required to complete]).
Round 2
In Round 2, all questionnaires suggested in Round 1 were supplied electronically to the experts along with their clinimetric properties. The experts were informed that the literature search performed by L.B. and M.S.K. regarding the clinimetric properties was not exhaustive (as this was impossible due to time constraints between the rounds) but focused on clinimetric properties as reported for the most suitable population. The most suitable population of our study was patients with low back pain or neck pain. When no information about clinimetric properties of the listed questionnaires was available for this population, we searched for patients with musculoskeletal pain, followed by chronic pain, primary care patients, and finally the general population. The search strings and clinimetric summaries for each questionnaire are available upon request. Experts were asked to rate each questionnaire on a 11-point Numeric Rating Scale, ranging from "Totally unsuitable" (Score: 0) to "Totally suitable" (Score: 10) for use in people at risk of developing or maintaining persistent musculoskeletal pain, such as low back pain and neck pain. Experts were asked to consider the clinimetric properties, content, feasibility, expertise, and personal experiences with administering the questionnaire in their ratings. No individualized feedback from Round 1 was provided to the experts.
Following Round 2, the percentage of experts who rated the questionnaire equal to or higher than a 7 on the 11-point suitability rating was calculated, and the questionnaires were ranked accordingly. For a questionnaire to be retained for Round 3, at least 50% of the experts had to rate the questionnaire with a score ≥7.
Round 3
In Round 3, a list of the highest ranked questionnaires (in random order, and with a maximum of 5 questionnaires per psychosocial factor) was provided to the experts. For each questionnaire, they were asked whether they considered this instrument suitable to assess the psychosocial factor in people at risk of developing or maintaining persistent musculoskeletal pain (such as low back pain or neck pain). The answering options were: Yes/No/Don't know. Furthermore, they were asked to share any positive or negative experiences with using the questionnaire in clinical practice or research.
This was an open-ended question.
We considered a priori that consensus was reached when at least 75% of the experts rated the instrument as suitable, for questionnaires that were rated by at least 50% of the experts. The "Don't know" scores were not taken into account to calculate the percentage to reach consensus.
All experts who completed Round 1 were asked to participate in Round 3, regardless of their participation in Round 2. A sensitivity analysis was added to determine whether the results differed if only the data provided by experts who participated in all rounds were taken into consideration since 5 experts did not participate in round 2. A second sensitivity analysis was conducted to determine whether the results would differ if only the data provided by experts who participated in all rounds were taken into consideration rather than including the data of experts who did not complete Round 2. In this sensitivity analysis, we excluded the scores provided by experts who were involved in the development and/or validation of a questionnaire from the analyses for that specific questionnaire and recalculated agreement percentages.
The positive and negative experiences collected in Round 3 were analyzed qualitatively using thematic content analysis 16 by 2 independent investigators (L.B. and M.S.K.). If the identified themes differed, the investigators tried to resolve the discrepancies through discussion. If unsuccessful, a third investigator was consulted (G.S.P.).
Results

Expert Panel
Via PubReMiner, we identified 77 people who met our criteria to be an expert on the panel and who we invited to participate in the Delphi study (Fig 1) . Twenty-two experts accepted the invitation (response rate 29%). Together, they published over 5500 articles in peerreviewed journals. The most common professional backgrounds of the experts were Psychology (68%) and Medicine (23%). Table 1 describes the characteristics of the expert panel members.
Round 1
Nine questionnaires were suggested to assess depression, 8 to assess anxiety and 7 to assess somatization. Table 2 provides an overview of all suggested questionnaires.
Round 2
The top 5 questionnaires for depression and somatization were retained for Round 3. For anxiety, only 3 instruments were retained due to the fact that less than 50% of the experts graded the other instruments with a score ≥7 on the suitability rating scale (see Table 2 ). The percentage of scores which were higher or equal to 7 on the suitability rating scale is presented for each questionnaire in Table 2 . The response rate for Round 2 was 64%.
Round 3
For each psychosocial factor, the panel reached consensus on whether or not to recommend the instruments. The results are summarized in Table 3 . The response rate for Round 3 was 73%. For each psychosocial factor, the main findings are summarized below.
Depression
The panel reached consensus on the following preferred questionnaires to assess depression: Depression subscale of the Depression, Anxiety and Stress Scales Short Form (DASS 21-D), Patient Health Questionnaire (PHQ-9), Beck Depression Inventory (BDI-II), and Center for Epidemiological Studies Depression Scale (CES-D; Table 3 ). In the complete-group analysis, the Depression Subscale of the Hospital Anxiety Depression Scale (HADS-D) just failed to reach the level of consensus (73% agreement). However, consensus for this subscale was reached in the sensitivity analyses (see below).
Anxiety
All 3 instruments to assess anxiety that were retained for Round 3 were considered preferred questionnaires by our panel of experts. The highest scoring instrument was the Pain Anxiety Symptoms Scale (PASS), followed by the State and Trait Anxiety Inventory (STAI), and the Generalized Anxiety Disorder Scale (GAD-7).
Somatization
It must be noted that half of the experts challenged the construct of somatization in people at risk of developing or maintaining persistent musculoskeletal pain and that many of the remaining experts were unfamiliar with most suggested instruments which is why no recommendation could be made.
Qualitative Analysis
Experts valued instruments that were clinimetrically sound, widely studied, available in multiple languages, and user-friendly (ie, easy-to-understand items, easy-toscore, and limited number of items). The positive and negative experiences with using the questionnaires in clinical practice and research are listed in Appendix D. The responses reflected 4 underlying themes:
Questionnaires for subpopulations
The PHQ-9, DASS, and CES-D were preferred by a majority of the experts to assess depression in patients with musculoskeletal pain in a community setting, while 
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the BDI was preferred for psychiatric patients with comorbid pain symptoms. For anxiety, most experts deemed the PASS and the STAI as most pain specific, while the GAD-7 was more appropriate for generalized anxiety symptoms.
Inclusion of somatic symptoms in questionnaires for depression and anxiety
For depression and anxiety, 3 experts preferred questionnaires such as the HADS and DASS-21 as these instruments do not include items regarding somatic symptoms of depression and anxiety. These 3 experts also preferred the HADS because it was developed and validated in patients with physical health conditions 38 as opposed to people with mental health disorders or a community sample. They expressed the opinion that pain can influence the patient's score on other questionnaires that include somatic symptoms of depression and anxiety, threatening the construct validity. In contrast, 3 other experts considered somatic symptoms an essential part of depression and anxiety. According to these experts, the construct validity would be flawed by not including items regarding the somatic symptoms of depression and anxiety.
Validity of the HADS subscales
Three experts expressed concern regarding the discriminant validity of the HADS subscales. The standalone use of the subscales was considered not stable or reliable enough and the HADS seems to load on a single factor ("which might be distress") as opposed to the 2 factors depression and anxiety separately.
The construct of somatization
Eight experts described the construct of somatization as unclear "because sometimes somatization is used as the tendency to report unresolved psychological issues as physical symptoms while for some it simply means many somatic symptoms." These 8 experts advised against screening for somatization in patients at risk of developing or maintaining persistent musculoskeletal pain.
Sensitivity Analyses
Firstly, we performed a sensitivity analysis to verify whether or not participating in the second round influenced our final results, as we invited everyone who participated in Round 1 to participate in Round 3, irrespective of whether they had participated in Round 2. Five experts did not participate in Round 2. For depression, consensus was reached in the sensitivity analysis for the same 4 questionnaires (DASS-21-D, PHQ-9, BDI-II, and CES-D) that were preferred in the complete-group analysis. The levels of agreement were slightly different, resulting in a different ranking of the preferred questionnaires (see Appendix B). Furthermore, in the sensitivity analysis, the level of agreement (81%) for the HADS-D met the consensus threshold, whereas in the complete-group analysis the level of agreement (73%) fell just below the consensus threshold of 75%. For anxiety, the agreement levels in the sensitivity analysis were slightly different, resulting in a different ranking of instruments, but consensus was reached for the same questionnaires. Because many experts (50%) questioned the construct of somatization and/or its applicability in patients at risk of developing or maintaining persistent musculoskeletal pain, the number of experts was insufficient for a sensitivity analysis of the somatization questionnaires. Secondly, we performed a sensitivity analysis to determine if the recommendations would differ if the experts who participated in the development and/or validation of a suggested questionnaire were excluded from the analyses of that particular questionnaire. For depression and anxiety, consensus was reached for the same questionnaires, in the same order, with slightly lower agreement percentages (see Appendix C). For the same reasons as mentioned above, this sensitivity analysis was not performed for somatization.
Discussion
In the first round of this Delphi study, the experts suggested 24 suitable instruments to assess depression, anxiety, and somatization in patients at risk of developing or maintaining musculoskeletal pain (such as low back pain or neck pain). Following the different rounds, this number could be reduced substantially and consensus was reached for 8 instruments. The DASS-21-D, PHQ-9, BDI-II, CES-D, and HADS-D were identified as the preferred questionnaires to assess depression. It should be noted that the HADS-D just failed to reach the threshold for consensus in the complete-group analysis, but the threshold was reached in the sensitivity analyses. We therefore suggest that the recommendation for the HADS-D should be interpreted more prudently. The PASS, STAI, and GAD-7 emerged as the preferred questionnaires to assess anxiety in patients with musculoskeletal pain. For somatization, no recommendation could be made.
When considering the clinimetric properties of the preferred questionnaires, an important consideration is that only a few of these recommended questionnaires are validated in people with pain (BDI 17, 29 ; DASS-21-D 26 ; STAI 37 ; and PASS 23 ). Following the outcomes of this Delphi study, priority can be directed toward validation of the preferred questionnaires in patients with musculoskeletal pain. This is opportune as psychosocial factors are important predictors for poor recovery in people with musculoskeletal pain. 18 It will further encourage the broad implementation of these questionnaires which will facilitate easier comparison and pooling of baseline and outcome data in both research and clinical practice.
The qualitative data offer further insight in the recommended questionnaires. For example, for depression, the validity, and reliability of the subscales of the HADS were questioned. This is in line with the current literature as the factor structure of the HADS seems to vary with the method of analysis that is used. 11 Some researchers advise revision of the HADS rather than *N provided is the number of experts adjusted for the panel members who did not consider themselves as an expert for this factor. yEight experts deemed the construct of somatization to be unclear or irrelevant for people with musculoskeletal pain. zIf less than 50% of experts had an opinion about a questionnaire, the questionnaire was withdrawn from further analysis. For the meaning of the abbreviations of the questionnaires, please see Table 2 .
xThreshold for consensus was reached in the sensitivity analysis (see Appendix B).
abandonment. 35 Also according to the qualitative comments, the appropriateness of the recommended questionnaires for anxiety may depend on the situation. The GAD-7 is believed to be more suitable to measure generalized anxiety, while the PASS is more specifically targeting anxiety relating to pain. This study revealed that half of our expert panel questioned the construct of somatization in people with musculoskeletal pain. As these experts did not recommend to screen for somatization in this population, they did not suggest or score questionnaires. Consequently, although the preferred questionnaire, the PHQ-15 was not broadly supported and therefore not recommended. As somatization research is a less welldeveloped field in comparison to depression and anxiety, there were fewer people available for the construct of somatization (N = 8) who met our criteria to be included in the expert panel and who were familiar with the questionnaires for this domain. There is little empirical evidence on the optimal number of experts to achieve a reliable and valid consensus process. 30 However, most Delphi studies use panel's report using panels that consist of 15 to 20 experts. 19, 30 In general, there are no clear guidelines as to what methods are preferred for conducting a (modified) Delphi study, and it has been criticized in terms of replicability. 20 We have therefore aimed to be as transparent as possible in reporting in accordance with the recommendations made by Humphrey-Murto et al. 20 By choosing for 3 rounds prior to the study to improve completion rates, 33 and including experts in the third round regardless of their participation in the second round we have potentially added a bias in reaching consensus. However, in the sensitivity analysis most recommendations remained valid, with the exception of the HADS-D. Another limitation of the Delphi method is that instruments that are well established in a particular field may be favored, and newly developed and less frequently studied questionnaires may be disadvantaged. This study represents the current state of research.
Lastly, we have provided the experts with clinimetric properties for each questionnaire in a relevant population. As this was not based on a full systematic review, this could have introduced some bias in the experts' recommendations. However, clinimetric properties were only one element the experts were asked to take into consideration, besides content, feasibility, personal experiences and expertise.
A strength of the study is the quality of the expert panel which consisted of 22 international experts who were both highly qualified (ie, 91% have a PhD-degree) and experienced (with an average of over 20 years of experience). The experts were from various relevant professional backgrounds (Psychology, Medicine, and Allied Health). This diversity makes the results of this study applicable to a variety of health care domains. 7 Two thirds of our expert panel consisted of psychologists and this might have led to a bias in recommendations. However, given that we focused on the psychosocial factors psychologists are most likely to work with (depression, anxiety, and somatization), we believe that the expert panel is a good reflection of the experts in this field. The response rates for all rounds were in line with previous research, with approximately two thirds of experts responding in Rounds 2 and 3 12 and the size of the expert panel for depression and anxiety (N = 16) is in line with the recommended size. 19 Recommendations generated through this study might aid the screening for psychosocial factors in general practice and these questionnaires can be added in research when these variables are core outcomes. There have been core outcome sets developed for patients with musculoskeletal pain. 10 Currently, the core outcome measure index for low back pain 8 does not include the psychosocial dimension although consensus was nearly reached for the domain of "psychosocial functioning." 9 Chiarotto et al proceed to recommend the BDI-II, the HADS, and the CES-D as most-frequently used instruments for this domain. 9
Conclusion
Following a 3-round Delphi study, the expert panel reached consensus on the recommendation of the following instruments to measure depression and anxiety in people at risk of developing or maintaining persistent musculoskeletal pain (such as low back pain or neck pain). For depression, the DASS-21-D, PHQ-9, BDI-II, CES-D, and HADS-D; for anxiety: the STAI, PASS, and GAD-7; and for somatization: no recommendation could be made. Priority can be directed to validating these measures in a population of patients with musculoskeletal pain.
